Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hepatitis C Virus Infection Cycle-Specific MicroRNA Profiling Reveals Stage-Specific miR-4423-3p Targets RIG-I to Facilitate Infection. | Front Cell Infect Microbiol | 2022 | 35402303 | PubTator, text mining | PubMed |
| EGFR-RAD51 gene fusion NSCLC responsiveness to different generation EGFR-TKIs: two cases and review of the literature. | Transl Lung Cancer Res | 2022 | 35399574 | PubTator, text mining | PubMed |
| The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review. | Transl Lung Cancer Res | 2022 | 35399571 | PubTator, text mining | PubMed |
| Current Debates on Etiopathogenesis and Treatment Strategies for Vitiligo. | Curr Drug Targets | 2022 | 35388753 | PubTator, text mining | PubMed |
| Matrix stiffness exacerbates the proinflammatory responses of vascular smooth muscle cell through the DDR1-DNMT1 mechanotransduction axis. | Bioact Mater | 2022 | 35386458 | PubTator, text mining | PubMed |
| Physical and functional interactome atlas of human receptor tyrosine kinases. | EMBO Rep | 2022 | 35384245 | PubTator, text mining | PubMed |
| SPCS: a spatial and pattern combined smoothing method for spatial transcriptomic expression. | Brief Bioinform | 2022 | 35380614 | PubTator, text mining | PubMed |
| lncRNA LEF1-AS1 Acts as a Novel Biomarker and Promotes Hypopharyngeal Squamous Cell Carcinoma Progression and Metastasis by Targeting the miR-221-5p/GJA1 Axis. | Dis Markers | 2022 | 35371339 | PubTator, text mining | PubMed |
| circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis. | Genet Res (Camb) | 2022 | 35356749 | PubTator, text mining | PubMed |
| Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib. | Cancer Biol Ther | 2022 | 35343367 | PubTator, text mining | PubMed |
| Epigenetic changes in the metabolically healthy obese: A case-control versus a prospective study. | Eur J Clin Invest | 2022 | 35342930 | PubTator, text mining | PubMed |
| Hepatic kinome atlas: An in-depth identification of kinase pathways in liver fibrosis of humans and rodents. | Hepatology | 2022 | 35313030 | PubTator, text mining | PubMed |
| The Collagen Receptor Discoidin Domain Receptor 1b Enhances Integrin β1-Mediated Cell Migration by Interacting With Talin and Promoting Rac1 Activation. | Front Cell Dev Biol | 2022 | 35309920 | PubTator, text mining | PubMed |
| A Systematic Review of Tissue and Single Cell Transcriptome/Proteome Studies of the Brain in Multiple Sclerosis. | Front Immunol | 2022 | 35309325 | PubTator, text mining | PubMed |
| Molecular Features of a Primary Transmural Tracheal Schwannoma: Clinical Experience and Review of the Literature. | Cancer Manag Res | 2022 | 35308086 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Effects of DDR1 on migration and adhesion of periodontal ligament cells and the underlying mechanism. | J Periodontal Res | 2022 | 35297053 | PubTator, text mining | PubMed |
| LncRNA SNHG12 promotes the malignant progression of melanoma by targeting miR-199b. | Ann Transl Med | 2022 | 35280401 | PubTator, text mining | PubMed |
| Unsupervised Learning in Drug Design from Self-Organization to Deep Chemistry. | Int J Mol Sci | 2022 | 35269939 | PubTator, text mining | PubMed |
| The Role of Extracellular Matrix Proteins in Breast Cancer. | J Clin Med | 2022 | 35268340 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=36